Nanoviricides Inc (NNVC)
1.47
+0.05
(+3.52%)
USD |
NYAM |
Nov 04, 16:00
1.465
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Net Income (Annual): -8.294M for June 30, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.294M |
| June 30, 2023 | -8.589M |
| June 30, 2022 | -8.107M |
| June 30, 2021 | -8.822M |
| June 30, 2020 | -13.45M |
| June 30, 2019 | -8.424M |
| June 30, 2018 | -8.564M |
| June 30, 2017 | -10.30M |
| June 30, 2016 | -10.72M |
| June 30, 2015 | -2.198M |
| Date | Value |
|---|---|
| June 30, 2014 | -13.60M |
| June 30, 2013 | -8.876M |
| June 30, 2012 | -6.207M |
| June 30, 2011 | -6.477M |
| June 30, 2010 | -4.744M |
| June 30, 2009 | -2.788M |
| June 30, 2008 | -2.738M |
| June 30, 2007 | -3.119M |
| June 30, 2006 | -3.284M |
| June 30, 2005 | -0.066M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-13.45M
Minimum
2020
-8.107M
Maximum
2022
-9.452M
Average
-8.589M
Median
2023
Net Income (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -29.74M |
| iBio Inc | -24.91M |
| Theriva Biologics Inc | -18.35M |
| Oragenics Inc | -20.66M |